1. Home
  2. RGNX vs GIG Comparison

RGNX vs GIG Comparison

Compare RGNX & GIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • GIG
  • Stock Information
  • Founded
  • RGNX 2008
  • GIG 2024
  • Country
  • RGNX United States
  • GIG United States
  • Employees
  • RGNX N/A
  • GIG N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • GIG
  • Sector
  • RGNX Health Care
  • GIG
  • Exchange
  • RGNX Nasdaq
  • GIG NYSE
  • Market Cap
  • RGNX 387.0M
  • GIG 334.0M
  • IPO Year
  • RGNX 2015
  • GIG 2024
  • Fundamental
  • Price
  • RGNX $6.76
  • GIG $10.12
  • Analyst Decision
  • RGNX Strong Buy
  • GIG
  • Analyst Count
  • RGNX 9
  • GIG 0
  • Target Price
  • RGNX $32.89
  • GIG N/A
  • AVG Volume (30 Days)
  • RGNX 1.0M
  • GIG 23.8K
  • Earning Date
  • RGNX 05-07-2025
  • GIG 01-01-0001
  • Dividend Yield
  • RGNX N/A
  • GIG N/A
  • EPS Growth
  • RGNX N/A
  • GIG N/A
  • EPS
  • RGNX N/A
  • GIG 0.10
  • Revenue
  • RGNX $83,328,000.00
  • GIG N/A
  • Revenue This Year
  • RGNX $285.14
  • GIG N/A
  • Revenue Next Year
  • RGNX N/A
  • GIG N/A
  • P/E Ratio
  • RGNX N/A
  • GIG $97.54
  • Revenue Growth
  • RGNX N/A
  • GIG N/A
  • 52 Week Low
  • RGNX $5.62
  • GIG $9.89
  • 52 Week High
  • RGNX $21.19
  • GIG $10.18
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 41.59
  • GIG N/A
  • Support Level
  • RGNX $7.96
  • GIG N/A
  • Resistance Level
  • RGNX $8.35
  • GIG N/A
  • Average True Range (ATR)
  • RGNX 0.65
  • GIG 0.00
  • MACD
  • RGNX -0.04
  • GIG 0.00
  • Stochastic Oscillator
  • RGNX 13.21
  • GIG 0.00

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About GIG GIGCAPITAL7 CORP.

GigCapital7 Corp is a Private-to-Public Equity (PPE) company, also known as a blank check company or special purpose acquisition company.

Share on Social Networks: